These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84 related articles for article (PubMed ID: 9738829)
1. Interactions of plaunotol with bacterial membranes. Koga T; Watanabe H; Kawada H; Takahashi K; Utsui Y; Domon H; Ishii C; Narita T; Yasuda H J Antimicrob Chemother; 1998 Aug; 42(2):133-40. PubMed ID: 9738829 [TBL] [Abstract][Full Text] [Related]
2. Bactericidal effect of plaunotol, a cytoprotective antiulcer agent, against Helicobacter pylori. Koga T; Kawada H; Utsui Y; Domon H; Ishii C; Yasuda H J Antimicrob Chemother; 1996 Sep; 38(3):387-97. PubMed ID: 8889714 [TBL] [Abstract][Full Text] [Related]
3. In-vitro and in-vivo antibacterial activity of plaunotol, a cytoprotective antiulcer agent, against Helicobacter pylori. Koga T; Kawada H; Utsui Y; Domon H; Ishii C; Yasuda H J Antimicrob Chemother; 1996 May; 37(5):919-29. PubMed ID: 8737142 [TBL] [Abstract][Full Text] [Related]
4. Effect of plaunotol in combination with clarithromycin against clarithromycin-resistant Helicobacter pylori in vitro and in vivo. Sasaki M; Mizoshita T; Mizushima T; Inoue H; Kamiya T; Kataoka H; Ogaswara N; Wada T; Kubota E; Mori Y; Shimura T; Hirata H; Ando K; Okamoto Y; Ohara H; Nakao H; Joh T J Antimicrob Chemother; 2007 Nov; 60(5):1060-3. PubMed ID: 17827146 [TBL] [Abstract][Full Text] [Related]
5. Effect of plaunotol in combination with clarithromycin or amoxicillin on Helicobacter pylori in vitro and in vivo. Koga T; Inoue H; Ishii C; Okazaki Y; Domon H; Utsui Y J Antimicrob Chemother; 2002 Jul; 50(1):133-6. PubMed ID: 12096020 [TBL] [Abstract][Full Text] [Related]
6. Synthesis of plaunotol derivatives and their antibacterial activities against Helicobacter pylori. Tago K; Minami E; Masuda K; Akiyama T; Kogen H Bioorg Med Chem; 2001 Jul; 9(7):1781-91. PubMed ID: 11425580 [TBL] [Abstract][Full Text] [Related]
7. Plaunotol suppresses interleukin-8 secretion induced by Helicobacter pylori: therapeutic effect of plaunotol on H. pylori infection. Takagi A; Koga Y; Aiba Y; Kabir AM; Watanabe S; Ohta-Tada U; Osaki T; Kamiya S; Miwa T J Gastroenterol Hepatol; 2000 Apr; 15(4):374-80. PubMed ID: 10824880 [TBL] [Abstract][Full Text] [Related]
8. A highly stereoselective synthesis of plaunotol and its thiourea derivatives as potent antibacterial agents against Helicobacter pylori. Kogen H; Tago K; Arai M; Minami E; Masuda K; Akiyama T Bioorg Med Chem Lett; 1999 May; 9(10):1347-50. PubMed ID: 10360733 [TBL] [Abstract][Full Text] [Related]
9. Bactericidal effect of ecabet sodium on clarithromycin- and metronidazole-resistant clinical isolates of Helicobacter pylori. Shibata K; Kasuga O; Yasoshima A; Matsushita T; Kawakami Y Jpn J Antibiot; 1997 Jun; 50(6):525-31. PubMed ID: 9258741 [TBL] [Abstract][Full Text] [Related]
10. [Prevalence of resistance to metronidazole in Helicobacter pylori from children and induction of resistance in vitro]. Hu HJ; Chen J; Yan WH; Zhang XP Zhonghua Er Ke Za Zhi; 2007 Oct; 45(10):765-8. PubMed ID: 18211761 [TBL] [Abstract][Full Text] [Related]
11. Sucralfate affects the susceptibility of Helicobacter pylori to antimicrobial agents. Slomiany BL; Piotrowski J; Majka J; Slomiany A Scand J Gastroenterol Suppl; 1995; 210():82-4. PubMed ID: 8578215 [TBL] [Abstract][Full Text] [Related]
12. Bactericidal and morphological effects of NE-2001, a novel synthetic agent directed against Helicobacter pylori. Dai G; Cheng N; Dong L; Muramatsu M; Xiao S; Wang MW; Zhu DX Antimicrob Agents Chemother; 2005 Aug; 49(8):3468-73. PubMed ID: 16048962 [TBL] [Abstract][Full Text] [Related]
13. The susceptibility of Campylobacter pylori to antiulcer agents and antibiotics. Nagate T; Numata K; Hanada K; Kondo I J Clin Gastroenterol; 1990; 12 Suppl 1():S135-8. PubMed ID: 2212539 [TBL] [Abstract][Full Text] [Related]
14. Metronidazole resistance and virulence factors in Helicobacter pylori as markers for treatment failure in a paediatric population. López-Brea M; Martínez MJ; Domingo D; Sánchez I; Alarcón T FEMS Immunol Med Microbiol; 1999 Jun; 24(2):183-8. PubMed ID: 10378418 [TBL] [Abstract][Full Text] [Related]
15. Adding once-daily omeprazole 20 mg to metronidazole/amoxicillin treatment for Helicobacter pylori gastritis: a randomized, double-blind trial showing the importance of metronidazole resistance. Veldhuyzen van Zanten S; Hunt RH; Cockeram A; Schep G; Malatjalian D; Sidorov J; Matisko A; Jewell D Am J Gastroenterol; 1998 Jan; 93(1):5-10. PubMed ID: 9448164 [TBL] [Abstract][Full Text] [Related]
16. Combination therapy with mucosal protective agent for the eradication of Helicobacter pylori. Fukuda Y; Yamamoto I; Okui M; Tonokatsu Y; Tamura K; Shimoyama T Eur J Gastroenterol Hepatol; 1995 Aug; 7 Suppl 1():S45-7. PubMed ID: 8574735 [TBL] [Abstract][Full Text] [Related]